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BAX Is Required for Neuronal Death
after Trophic Factor Deprivation
and during Development
Thomas L. Deckwerth,*§ Jeffrey L. Elliott,†§ regulation of cell death (Yin et al., 1994; Chittenden et
al., 1995b). The apoptosis-promoting protein BAX dis-C. Michael Knudson,‡§ Eugene M. Johnson, Jr.,*
plays a broad capability to form heterodimers with multi-William D. Snider,† and Stanley J. Korsmeyer‡
ple members (BCL2, BCLxL, MCL1, A1) (Sato et al., 1994;*Department of Molecular Biology and Pharmacology
Sedlak et al., 1995), and all of these genes can be coex-†Department of Neurology
pressed ina single cell type (Merry et al., 1994; Krajewski‡Department of Medicine and Pathology
et al., 1994; Gonzalez-Garcia et al., 1994; Greenlund etHoward Hughes Medical Institute
al., 1995b). Overexpression of BAX counters the protec-Washington University School of Medicine
tion afforded by antagonistic members such as BCL2St. Louis, Missouri 63110
and BCLxL and promotes apoptosis. One model (the
rheostat model) consistent with such data holds that a
critical level of BAX homodimers activates downstreamSummary
death effector molecules and that antagonists such as
BCL2 prevent death by inactivating BAX through hetero-Members of the BCL2-related family of proteins either
dimerization (Oltvai et al., 1993; Oltvai and Korsmeyer,promote or repress programmed cell death. BAX, a
1994). In addition, there may exist a survival-promotingdeath-promoting member, heterodimerizes with mul-
pathway that can be activated by BCLxL without requir-tiple death-repressing molecules, suggesting that it
ing heterodimerization with BAX (Cheng et al., 1996).could prove critical to cell death. We tested whether
However, none of these studies established clearlyBax is required for neuronal death by trophic factor
whether the death agonist or antagonist molecules aredeprivation and duringdevelopment. Neonatal sympa-
dominant in determining cellular viability after a death-thetic neurons and facial motor neurons from Bax-
inducing stimulus. Thus, it was uncertain whether BAXdeficient mice survived nerve growth factor depriva-
could prove of singular importance in mediating an exe-tion and disconnection from their targets by axotomy,
cution signal in a selected cell type.respectively. These salvaged neurons displayed re-
Neuronal cell death plays a prominent role during themarkable soma atrophy and reduced elaboration of
normal development of the vertebrate nervous systemneurites; yet they responded to readdition of trophic
(reviewed by Oppenheim, 1991). At least half of the neu-factor with soma hypertrophy and enhanced neurite
rons that are generated in many populations die duringoutgrowth. Bax-deficient superior cervical ganglia and
specific developmental periods. This neuronal death isfacial nuclei possessed increased numbers of neu-
largely controlled by the availability of target-derivedrons. Our observations demonstrate that trophic fac-
trophic factors to the distal nerve endings, once thetor deprivation–induced death of sympathetic and mo-
neurons have become trophic factor–dependent and ex-tor neurons depends on Bax.
tend axons into their target areas. The mechanisms un-
derlying neuronal death after trophic factor deprivationIntroduction
have been studied extensively in the sympathetic ner-
vous system and in motor neurons. Neonatal sympa-
Extensive programmed cell death occurs during the de-
thetic neurons depend on nerve growth factor (NGF) for
velopment and the maintenance of tissues of multicellu-
survival (Levi-Montalcini and Booker, 1960; Gorin and
lar organisms (reviewed by Glu¨cksmann, 1951). Early
Johnson, 1979; Crowley et al., 1994). In the absence of
insights into the regulation of programmed cell death
NGF, the death-inducing stimulus, sympathetic neurons
arose from the analysis of the molecular mechanisms die by apoptosis (Deckwerth and Johnson, 1993; Batis-
underlying follicular B-cell lymphoma and genetic stud-
tatou and Greene, 1993; Edwards and Tolkovsky, 1994).
ies of the stereotypic cell deaths in nematode develop-
Neuronal death by trophic factor deprivation has been
ment. This led to the identification of homologous potent
shown to be modulated by the levels of BCL2 family
death repressors including the human Bcl2 (Tsujimoto members. BCL2, BAX, and BCLxL are expressed in NGF-et al., 1985; Bakhshi et al., 1985; Cleary and Sklar, 1985) maintained neurons in vitro (Greenlund et al., 1995b)
and the nematode Ced9 gene (Hengartner and Horvitz, and in vivo (Krajewski et al., 1994; Miyashita et al., 1994).
1994). The Bcl2 family of genes now consists of both Overexpression of BCL2 (Garcia et al., 1992; Borner et
apoptosis-promoting molecules (e.g., Bax, Bad, Bak, al., 1994; Greenlund et al., 1995a) or BCLxL (Frankowski
BclxS) and antagonists (e.g., Bcl2, BclxL, Mcl1, Ced9) et al., 1995) by microinjection of expression vectors into
whose gene products have been implicated as regula- sympathetic neurons retarded the kinetics of neuronal
tors of death in many cell types (Oltvai et al., 1993; Boise death after NGF withdrawal. Conversely, BCLxS reduced
et al., 1993; Kozopas et al., 1993; Yang et al., 1995; the neuroprotection afforded by BCL2 (Martinou et al.,
Farrow et al., 1995; Chittenden et al., 1995a; Kiefer et 1995) and BAK accelerated neuronal death (Farrow et
al., 1995). These proteins function, at least in part, via al., 1995), consistent with their respective roles as death
competing protein interactions. Several conserved do- agonists and antagonists.
mains termed BH1, BH2, and BH3 are required for the For motor neurons, deprivation of target-derived
formation of various heterodimers as well as for the growth factors produced by peripheral nerve axotomy
rapidly leads to death in the postnatal period unless
exogenous growth factors are supplied (reviewed by§These authors contributed equally to this work.
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Snider et al., 1992). In this experimental paradigm, as
well as during the period of developmental cell death,
motor neuron survival is modulated by BCL2. Murine
facial motor neurons overexpressing BCL2 survived the
period of naturally occurring neuronal death in larger
numbers than control neurons (Martinou et al., 1994)
and resisted degeneration after disconnection from their
source of trophic support after axotomy (Dubois-Dau-
phin et al., 1994). Likewise, spinal motor neurons were
partially protected from both insults by elevated levels of
BCL2 (Farlie et al., 1995). These gain-of-function studies
with Bcl2 family members have documented that the
common pathway of programmed cell death is involved
in these neuronal deaths.
Because of the capacity for multiple interactions
among BCL2 family members, overexpression studies
cannot assure the singular importance of a particular
member. The role of the death-repressing proteins
BCLxL and BCL2 in neuronal development has been
examined in mice in which these genes were inactivated
by targeted deletion. These loss-of-function studies
identified BCLxL as a critical positive regulator of neu-
ronal survival at early developmental stages for sensory
neurons and CNS neurons that were differentiating after
having migrated out of the ventricular mitotic zone (Mo-
toyama et al., 1995). Mice deficient in Bcl2, however,
showed few overt developmental neuronal abnormali-
ties, suggesting that BCL2 plays less of a role in the
development of the nervous system (Veis et al., 1993;
Nakayama et al., 1994; Kamada et al., 1995). No studies
to date have addressed whether death-promoting BCL2
family members critically regulate survival of neurons.
In this study, we utilize Bax-deficient (Bax 2/2) mice,
the first knockout of a death-promoting family member Figure 1. Bax mRNA Expression in Sympathetic and Facial Motor
Neurons of Wild-Type Mice during the Period of Survival Depen-(Knudson et al., 1995), to assess the role of BAX in
dence on Target-Derived Neurotrophic Factorsneuronal cell death. Bax 2/2 mice display hyperplasia of
(A) Darkfield photomicrograph of a parasagittal section throughselected non-neuronal lineages, including lymphocytes
brainstem and neck of a newborn wild-type mouse demonstratesand ovarian granulosa cells, and demonstrate an un-
Bax expression in the sympathetic SCG (asterisk), the ventral pons
usual testicular degeneration. Yet, the Bax 2/2 lympho- at the level of the trigeminal motor nucleus (large arrowheads), and
cytes had no definable altered resistance to several the external germinal layer of the cerebellum (small arrowheads).
death stimuli (Knudson et al., 1995). In contrast, we find Scale bar, 200 mm.
(B) Brightfield high power photomicrograph of Bax mRNA expres-that Bax 2/2 sympathetic neurons are independent of
sion in motor neurons of the facial nucleus of P4 wild-type mice.NGF for survival and that neonatal motor neurons sur-
The large neurons with abundant eosinophilic cytoplasm (arrows)vive disconnection from their targets by axotomy. The
are motor neurons. Silver grains are present over motor neurons
trophic factor–independent neurons show reduced neu- but not over the surrounding glia. Scale bar, 25 mm.
rite outgrowth and have atrophic somas. Yet, they re-
spond to addition of trophic factor with enhanced neu-
neuronal populations are susceptible to growth factorrite outgrowth and soma hypertrophy. Furthermore,
deprivation. Besides being expressed in these two neu-developmental sympathetic and motor neuronal death
ronal types, Bax expression is also prominent in theis reduced in Bax 2/2 mice. Thus, BAX is required for
pons at the level of the trigeminal motor nucleus and inneuronal death after deprivation of neurotrophic factors.
the external germinal layer of the developing cerebellum
(Figure 1), among others, suggesting functions in the
CNS beyond motor neurons.Results
Bax mRNA Levels Are High in Sympathetic Survival of Bax 2/2 Sympathetic Neurons
Is Trophic Factor–Independentand Facial Motor Neurons
BAX is expressed in a temporal and spatial pattern com- The role of BAX in neuronal death by trophic factor
deprivation was examined in a severe experimentalpatible with it having a role in regulating neuronal sur-
vival during development. Wild-type (Bax 1/1) neonatal model. Neonatal sympathetic neurons from SCGsof Bax
2/2, Bax 1/2, and Bax 1/1 mice were enzymaticallysympathetic superior cervical ganglion (SCG) neurons
(Figure 1A, asterisk) and facial motor neurons (Figure and mechanically dissociated into single cells, and
plated on collagen in medium containing neutralizing1B, arrows) express Bax mRNA at a time when these
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Figure 2. Bax 2/2 Sympathetic Neurons Are
NGF-Independent for Survival
(A) Survival of freshly plated wild-type (1/1),
heterozygous (1/2), and Bax-deficient (2/2)
sympathetic neurons exposed to anti-NGF
antiserum for 2 or 6 days followed by expo-
sure to NGF for 9 days. The number of neu-
rons was normalized to the mean number of
living neurons in cultures from the same ani-
mal maintained with NGF for 13 days (1000–
4600 neurons) and is indicated on the ordi-
nate. Only Bax 2/2 neurons survive plating
in the absence of NGF.
(B) Soma diameters of NGF-maintained and
NGF-deprived Bax 2/2 sympathetic neu-
rons. Sympathetic neurons plated in the ab-
sence of NGF for 10 days (A10, n 5 41) have
smaller somas than neurons maintained in
NGF for 10 days (N10, n 5 35), and somas
enlarge when exposed to NGF for 9 days fol-
lowing the period of NGF deprivation (A10N9,
n 5 43). The difference in soma size between
A10 and the other two conditions is statisti-
cally significant (* p < 0.0001, two-sided Mann
Whitney U test).
(C) Survival of Bax 2/2, Bax 1/2, and wild-
type sympathetic neurons cultured for 7 days
in the presence of NGF and thereafter de-
privedof NGF for 35 hr to 23 days as indicated
on the abscissa. Survival after 35 hr and 8
days is normalized to the survival of NGF-
maintained 8-day-old cultures from the same
animal. Survival after 7, 14, and 23 days is normalized to the survival in NGF-maintained 13-day-old cultures from the same animal. The NGF-
maintained cultures contain between 1400 and 4700 neurons. Bax 2/2 neurons survive in the absence of NGF while Bax-expressing neurons
die rapidly and show a distinct Bax gene dosage effect.
(D) Soma diameters of Bax 2/2 sympathetic neurons maintained by NGF for 7 (N7), 15 (N15), or 23 (N23) days, plated in the presence of NGF
for 7 days and followed by 8 days of NGF deprivation (N7A8), or treated as N7A8 and then switched back to NGF for 8 days (N7A8N8). NGF
deprivation (N7A8) induces soma atrophy, which is reversed upon readdition of NGF (N7A8N8) (mean 6 SD, * p < 0.0001 compared with all
other conditions, two-sided Mann Whitney U test). A total number of 16, 29, 25, 33, and 38 somas was measured for conditions N7, N15,
N23, N7A8, and N7A8N8, respectively.
anti-NGF antibodies. Neonatal SCG neurons are nor- were only about half the diameter after 10 days of NGF
deprivation compared with NGF-maintained neuronsmally exquisitely NGF-dependent for survival, and virtu-
ally all wild-type neurons die within 2 days in this para- (see Figure 2B). Remarkably, however, the Bax 2/2 neu-
rons grew neurites in the absence of NGF (Figure 3B).digm. After 2 days, or an even more stringent 6 days,
of NGF deprivation, the cultures were exposed to NGF- When examined by phase contrast microscopy or immu-
nofluorescence with an anti-neurofilament M antibody,containing medium and living neurons counted 9 days
later. This paradigm assesses whether the neurons re- the extent of neurite outgrowth from NGF-deprived neu-
rons was similar to that of NGF-maintained neurons aftermain alive during the period of NGF deprivation and
whether they are capable of long-term survival after 1 day (data not shown). Thereafter, neurite outgrowth
in the absence of NGF continued but was markedly lessaddition of NGF. Cultures from the same animal continu-
ously exposed to NGF for 13 days from the time of extensive than in the presence of NGF (Figures 3A and
3B). Most importantly, this atrophic appearance wasplating were used as control for neuronal survival medi-
ated by NGF. All neuronal numbers are presented nor- fully reversible when NGF was added to NGF-deprived
neurons. After exposure to NGF for 9 days, the somamalized to the mean number of neurons in these control
cultures. While all BAX-expressing neurons had died diameter (see Figures 2B and 3D) and neurite outgrowth
(Figure 3D) increased dramatically. These experimentswithin 2 days in the absence of NGF, Bax 2/2 neurons
survived NGF deprivation for 2 and 6 days and remained demonstrate that NGF-deprived neurons prevented
from dying by Bax deficiency retain a basic functionalalive for 9 additional days after NGF was added (Figure
2A). Therefore, we conclude that Bax 2/2 neurons do metabolism capable of producing NGF-independent
neurite outgrowth and are able to respond to additionnot require NGF for survival. Bax 1/2 neurons showed
no survival after 2 days of NGF deprivation, indicating of NGF with typical trophic responses such as soma
hypertrophy and enhanced neurite growth.that even a reduced gene dose of Bax can induce pro-
grammed cell death in neurons. However, the Bax gene To examine whether there was a gene dosage effect of
Bax on the kinetics of death, we examined sympatheticdose does affect the kinetics of death (see below).
Although all neurons survived, the morphology of neuronal death in a different experimental paradigm, in
which the kinetics of many molecular events underlyingNGF-deprived Bax 2/2 neurons (Figure 3B) differed
from that of NGF-maintained neurons (Figure 3A). NGF- programmed cell death have been studied (Deckwerth
and Johnson, 1993, 1994; Estus et al., 1994; Freemandeprived neurons had markedly smaller somas, which
Neuron
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Figure 3. Dissociated Bax 2/2 Neonatal Sympathetic Neurons Survive In Vitro in the Absence of NGF and Show Classical Trophic Responses
to Addition of NGF
(A) Primary cultures of dissociated Bax 2/2 murine sympathetic neurons maintained in NGF for 10 days.
(B) and (C) Bax 2/2 (B) and wild-type (C) neurons in the presence of anti-NGF antiserum for 10 days.
(D) Same field as (B), after an additional 9 days in the presence of NGF. Bax 2/2 sympathetic neurons survive in the absence of NGF (B) and
extend neurites. Their cell bodies remain atrophic. Upon addition of NGF (D), the somas hypertrophy and neurite outgrowth increases greatly.
Wild-type neurons die after withdrawal of NGF and their debris adheres to prominently visible collagen fibrils (C). Scale bar, 100 mm.
et al., 1994; Greenlund et al., 1995a, 1995b). Cultures of As in the more stringent paradigm, NGF deprivation
altered the morphology of SCG neurons. Their somassympathetic neurons from wild-type, Bax 1/2, and Bax
2/2 mice were first established in the presence of NGF atrophied greatly such that the soma diameter was re-
duced by about 40%after 8 days of NGF withdrawal (seefor 7 days before being deprived of NGF. In this para-
digm, more than 80% of all wild-type neurons have died Figure 2D) and the extent of neurite outgrowth appeared
diminished (data not shown). As for freshly plated neu-after 35 hr and all by 8 days after NGF deprivation.
In striking contrast, Bax 2/2 neurons survived in the rons (see Figure 2B), the soma atrophy was reversed
by readdition of NGF for 8 days (see Figure 2D).absence of NGF for 23 days, the last timepoint examined
(see Figure 2C). Bax 1/2 neurons died with slower kinet- A gene dosage effect of Bax on neuronal survival
would be consistent with the inactivation of Bax beingics than wild-type neurons, such that after 8 days 14%
of the Bax 1/2 neurons remained viable (see Figure solely responsible for the observed phenotype. To fur-
ther ensure that the massive reduction of trophic factor2C). The retarded kinetics of death of Bax 1/2 neurons
indicates that the gene dosage of Bax controls the kinet- deprivation–induced death was not an artifact caused
by a survival-promoting element introduced by theics of cell death after trophic factor withdrawal.
Besides assessing viability by phase contrast micros- 129SV strain, NGF deprivation–induced death of sympa-
thetic neurons was compared using both paradigmscopy and crystal violet staining, viability of NGF-
deprived Bax 2/2 neurons was also examined by stain- for 129SV mice, C57BL/6, and 129SV-C57BL/6 mice.
Neuronal death was comparable for all strains as longing with MTT, fluorescein diacetate, and Hoechst 33258
(Deckwerth and Johnson, 1994; data not shown). The as both copies of Bax were present (data not shown).
Furthermore, we have not observed any Bax-deficientcytoplasm of soma and neurites of NGF-deprived Bax
2/2 neurons stained dark blue with MTT, albeit weaker mouse whose neurons did not show a dramatic reduc-
tion of death after trophic factor deprivation.than NGF-maintained neurons, indicating a functional
energy metabolism. Neurites and soma showed green
fluorescence with fluorescein diacetate, indicating an BAX Is Required for Motor Neuron Death
Following Neonatal Axotomyintact plasma membrane and esterase activity. The nu-
clear chromatin stained homogeneously with Hoechst To determine whether BAX was necessary for neuronal
death by trophic factor deprivation in vivo, we used the33258 and showed the bright patches of heterochroma-
tin characteristic of murine nuclei while lacking any sign paradigm of facial nerve axotomy in which the motor
neurons in the facial nucleus are disconnected fromof an apoptotic nuclear morphology.
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Figure 4. Motor Neuron Survival 1 Week after Facial Nerve Transection at P1 in Bax 2/2 and Wild-Type Mice
(A) and (B) Transverse sections of the pons at the level of the facial motor nucleus in wild-type mice showing the control, contralateral
nonaxotomized (A), and ipsilateral axotomized facial nucleus (B). Almost all motor neurons degenerated after axotomy.
(C) and (D) Transverse section through the facial nucleus of a Bax 2/2 mouse showing the contralateral (C) and ipsilateral (D) facial nucleus.
Virtually all facial motor neurons survived axotomy in Bax 2/2 animals, but many neurons became markedly atrophic.
(E) High power view of Bax 2/2 facial motor neurons that survived after axotomy (arrows).
(F) Quantitation of the number of facial motor neurons after a facial nerve transection in Bax 1/1, Bax 1/2, and Bax 2/2 mice. Motor neuron
survival is presented as mean 6 SEM of the percentage of viable neurons on the lesioned side relative to the nonlesioned side. The means
for Bax 1/2 and Bax 2/2 animals were compared with the mean of Bax 1/1 mice using the Student’s t test (* p < 0.001; n, number of
animals). Scale bar, 100 mm (A–D); 25 mm (E).
the trophic support provided by facial muscles. When from neonatal mice, it was noted that the largest ganglia
would usually be later identified as being derived fromperformed on control Bax 1/1 P1 mice, this procedure
results in the loss of 90% of motor neurons by the sev- Bax 2/2 animals. Furthermore, the number of trypan-
blue excluding cells recovered after dissociation wasenth postoperative day. The axotomized wild-type mice
show loss of motor neurons and subsequent gliosis (Fig- larger for Bax 2/2 ganglia than for Bax expressing gan-
glia (data not shown). To determine the number of SCGure 4B) relative to the contralateral unoperated side (Fig-
ure 4A). In striking contrast, in Bax 2/2 mice, 86% of neurons in animals with different Bax gene dosage, pairs
of SCGs were dissected, dissociated, and allowed tothe facial motor neurons survived nerve transection and
there was only a limited glial reaction (Figures 4C–4F). adhere to collagen for 2 hr in the presence of NGF. The
The surviving neurons displayed considerable soma at- number of living neurons was determined after staining
rophy (Figures 4D and 4E). Bax 1/2 mice exhibited a with an anti-tyrosine hydroxylase antibody and the nu-
similar loss of motor neurons as Bax 1/1 mice, at the clear dye Hoechst 33258. Bax 2/2 ganglia yielded 2.5
time points assessed. and 1.8 times more neurons than wild-type and hetero-
Motorneurons in Bax2/2 animals survived into adult- zygous ganglia, respectively (Figure 6A). These data are
hood after nerve transection at P1. The facial nucleus consistent with a substantial reduction of naturally oc-
was still clearly discernible as a distinct cytoarchitec- curring death of sympathetic neurons during normal de-
tural unit 4 weeks after neonatal axotomy (Figure 5). velopment.
Facial motor neurons remained viable at this time, al- We next asked whether Bax 2/2 mice had an in-
though many of them were markedly atrophic. This pat- creased number of facial motor neurons following the
tern contrasts with that of Bax 1/2 and Bax 1/1 mice, period of developmental death. The contralateral nonax-
where facial motor neurons degenerated completely otomized facial nucleus was counted in 4-week-old
and were replaced with glia. These results demonstrate mice, revealing a 51% increase in neuronal number in
that BAX is obligate for the death of facial motor neurons Bax 2/2 mice relative to control Bax 1/1 mice (Figure
following axotomy-induced trophic factor withdrawal. 6B). The Bax 2/2 mice displayed a substantial increase
in the number of small- to medium-sized motor neurons,
while this population was less prominent in wild-typeDevelopmental Neuronal Death Is Reduced
mice. Bax 1/2 mice also demonstrated a modest in-in Bax 2/2 Mice
crease in the total number of facial motor neurons ofSince BAX was required for death to occur after trophic
z13%, which just achieved statistical significance.factor deprivation, we sought to determine whether BAX
Taken together, these results strongly suggest that nor-levels would influence developmental neuronal death,
mal developmental death is diminished in sympathetica process in which trophic factor deprivation appears
to play a prominent role. When ganglia were dissected and motor neurons from Bax 2/2 and Bax 1/2 mice.
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Figure 5. Motor Neurons in Bax 2/2 Mice Show Long-Term Survival Following Neonatal Axotomy
(A) and (B) Transverse sections of the facial nucleus 4 weeks after an ipsilateral axotomy performed at P1 in Bax 2/2 (A) and wild-type (B)
mice. In Bax 2/2 animals, the motor neurons did not die after prolonged target deprivation. In contrast, the facial nucleus in wild-type animals
was devoid of motor neurons and replaced with glial elements. Scale bar, 100 mm.
(C) and (D) High power magnification of images demarcated above in (A) and (B), respectively. The surviving facial motor neurons in Bax 2/2
mice are heterogeneous in size. Besides many very atrophic neurons (arrows) some neurons with large neuronal somas (arrowhead) are noted
as well. Scale bar, 25 mm.
Discussion trophic factor deprivation, but show long-term survival.
Despite the coexpression of multiple Bcl2 family mem-
bers within these neurons (Bcl2, BclxL, Mcl-1, Bax, Bak,Bax Is Required for Neuronal Death Induced
by Trophic Factor Deprivation and Bad) (prior references and S. J. K. and W. D. S.,
unpublished data), the apoptotic pathway induced byThe rheostat model hypothesizes that the balance be-
tween death-promoting and death-repressing members the deprivation of neurotrophic factor is remarkably de-
pendent upon a single member, Bax. The capacity ofof the BCL2 family contributes a critical checkpoint that
determines whether a cell will execute an apoptotic pro- Bax 2/2 sympathetic neurons to establish in culture
even in the absence of NGF is a rigorous test of theirgram after receiving a death stimulus (Oltvai et al., 1993;
Oltvai and Korsmeyer, 1994). The results of this study resistance to programmed cell death. Cell death in-
duced by neonatal axotomy of motor neurons was alsodemonstrate that in mice lacking BAX, sympathetic and
motor neurons do not die in the experimental setting of nearly completely prevented for at least 4 weeks by the
Figure 6. Bax Deficiency Suppresses Natu-
rally Occurring Neuronal Death of Sympa-
thetic and Facial Motor Neurons
(A) Number of viable sympathetic neuronsper
SCG after dissociation, plating in the pres-
ence of NGF for 2 hr, and identification of
living neurons by staining for tyrosine hydrox-
ylase and with Hoechst 33258. The number
of viable neurons per wild-type (1/1), hetero-
zygous (1/2), and Bax-deficient (2/2) gan-
glion is expressed as mean 6 SD and was
compared for Bax 2/2 ganglia with the num-
ber of neurons in wild-type or heterozygous
ganglia using the two-sided Student’s t test
(* p 5 0.0003; # p 5 0.0015).
(B) Facial motorneuron number in the nucleus
contralateral to axotomy of 4-week-old mice with different Bax genotypes. The number of neurons is presented as mean 6 SD and was
compared for Bax 1/2 and Bax 2/2 with the number of neurons in wild-type mice using the Student’s t test (# p < 0.04; * p < 0.001; n,
number of animals).
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absence of Bax. This latter finding importantly general- the signals in some experimental paradigms may be
stronger than in developmental deaths. For example, ifizes our result, as it constitutes a second cell type de-
pendent upon a different set of neurotrophic factors. trophic factor deprivation was accompanied by injury
that was to induce BAX in Bax 1/2 mice, the alteredOur results seem to conflict with recent work that
noted a weak survival-promoting effect when murine setpoint between pro- and anti-apoptotic Bcl2 family
members could further diminish a heterozygous effect.Bax was expressed in a number of trophic factor–
deprived neurons of a nonmammalian species (chicken) Such an increase in BAX protein has been observed in
CNS neurons following ischemic injury (Krajewski et al.,(Middleton et al., 1996). Our loss-of-function experi-
ments argue against a generalization of these results. 1995), providing support for this possibility.
While neurotrophic factor–dependent deaths wereSince single amino acid substitutions can alter the activ-
ity of BCL2 family proteins (Yin et al., 1994; Sedlak et al., abrogated in Bax 2/2 mice, BAX does not appear to
be requisite for all cell deaths. For example, the p53-1995), the overexpression of Bax from another species
might result in dominant negative effects or markedly dependent deaths of g-irradiated thymocytes are not
substantially altered in Bax 2/2 animals (Knudson etalter stoichiometry (Middleton et al., 1996). Taken to-
gether, these results indicate that the consequences of al., 1995). Moreover, when other lineages are quantified,
not every cell type reveals hyperplasia in Bax 2/2 mice.altering BCL2 family members can depend upon the
context in which they interact (Knudson et al., 1995). The existence of many classes of neurons expressing
differing subsets of BCL2 family members suggests that
the control of cell death may differ with lineage and
Bax Deficiency Reduces Developmental stage of development. Thus, while the Bax 2/2 mice
Neuronal Death provide the first testable model for the singular impor-
Bax deficiency also leads to a reduction in the extent tance of a death-promoting family member, models ex-
of naturally occurring developmental neuronal death. amining other death-promoting members such as BAD,
This finding demonstrates the developmental signifi- BAK, or BCLxS may prove their critical role in cell deaths
cance of the experimental resistance of Bax 2/2 neu- not obviously influenced by BAX.
rons to neurotrophic factor deprivation. During develop-
ment at E13-E18 in the mouse, 60% of the spinal motor
neurons initially generated undergo programmed cell Bax-Deficient Neurons Demonstrate that Neuronal
Survival Does Not Require Anabolic Responsesdeath (Lance-Jones, 1982; Oppenheim, 1991; Houenou
et al., 1994). Motor neuron death during this period can Induced by Trophic Factors
In addition to promoting survival, neurotrophic factorsbe greatly ameliorated by the addition of specific motor
neuron growth factors such as ciliary neurotrophic fac- exhibit anabolic effects on neuronal metabolism that
ultimately result in morphological changes such as in-tor, brain-derived neurotrophic factor, and glial cell line–
derived neurotrophic factor (GDNF), which also rescue creases in soma size and neurite outgrowth. Bax is not
involved in mediating these anabolic responses inducedmotor neurons from axotomy-induced death (Sendtner
et al., 1990; Oppenheim et al., 1992, 1995; Yan et al., by atrophic factors, since NGF induces these changes
in morphology in Bax-deficient sympathetic neurons as1992, 1995; Houenou et al., 1994). Bax 2/2 mice have
a 51% increase in the total number of facial motor neu- well as in wild-type neurons (Figures 2 and 3).
Conversely, the lack of anabolic stimulation uponrons, and it is likely that this increase is due to the
inability of motor neurons to complete the normal pro- withdrawal of trophic factors leads to atrophy. While
this atrophy is apparent in NGF-deprived wild-type sym-grammed cell death pathway in the absence of BAX.
Likewise, there are more sympathetic neurons in neona- pathetic neurons and its onset precedes the loss of
viability (Deckwerth and Johnson, 1993, 1994), the ex-tal Bax 2/2 SCG than in Bax-expressing ganglia. The
increased number of neurons is consistent with a de- tent of atrophy is much more prominent in neurons defi-
cient in Bax, because atrophy is not terminated by thecrease of naturally occurring cell death controlled by
NGF, since mouse sympathetic neurons start to respond induction of apoptosis (Figures 2 and 3). Likewise, Bax-
deficient motor neurons that survive neonatal axotomyto NGF with increased survival at E16-E17 (Coughlin
and Collins, 1985). It is conceivable that the increase in exhibit a morphology distinct from axotomized motor
neurons that survive following trophic factor administra-neuronal numbers may also reflect contributions of
NGF-independent processes. For example, it is un- tion. For example, GDNF administration prevents the
considerable atrophy that normally accompanies axo-tested whether Bax deficiency would at an earlier devel-
opmental stage affect the survival of sympathetic neuro- tomy and precedes death (Oppenheim et al., 1995; Yan
et al., 1995). In contrast, Bax deficiency prevents onlyblasts dependent onNT-3 or other trophic factors (Birren
et al., 1993; DiCicco-Bloom et al., 1993). neuronal death but not the neuronal atrophy that is very
apparent 1 week post-lesion and progresses during theNeurons heterozygous for Bax ultimately die following
experimental neurotrophic factor deprivation (Figures following weeks (Figures 4 and 5). The atrophy of trophic
factor–deprived neurons prevented from dying by Bax2A and 4E). However, the kinetics of death of NGF-
deprived Bax 1/2 sympathetic neurons was clearly re- deficiency illustrates that anabolic responses exerted
by trophic factor are not required for neuronal survival.tarded when neuronal cultures established for 7 days
in the presence of NGF were studied (Figure 2C). Bax The atrophic morphology noted in the extra motor
neurons surviving development illustrates the neuro-1/2 mice also demonstrated slightly enhanced num-
bers of sympathetic and motor neurons when compared trophic hypothesis of neuronal development. It states
that the survival of trophic factor–dependent neurons iswith wild-type mice (Figure 6). It is conceivable that
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regulated by limited amounts of target-derived trophic deprivation are arrested at a point where they are still
reversible. Therefore, in a neurodegenerative disease orfactors (reviewed by Oppenheim, 1991). With death
abolished by Bax deficiency, the coupling between lim- after an acute injury, in which BAX is critical in effecting
neuronal death, a BAX-specific inhibitor may be neuro-ited amounts of trophic factor leading to neuronal loss
is disrupted. The limiting amount of trophic factors in protective by stabilizing degenerating neurons prior to
the onset of irreversible damage. Since neurons retainthe invariable target is no longer reflected by diminished
neuronal survival but now manifests as atrophy of those the responsiveness to trophic factors and the ability
to reverse incurred degenerative changes at this point,supernumerary neurons. Despite the large number of
atrophic motor neurons and probably other neuronal treatment with a BAX-specific inhibitor holds the prom-
ise of a functional recovery of such salvaged neuronstypes, no abnormal behavior that might be related to
the reduction of developmental neuronal death has been upon exposure to trophic factors or upon elimination of
the diverse proximal defects responsible for triggeringnoted to date in the Bax 2/2 mice. It will be interesting
to see whether Bax 2/2 mice manifest an observable neuronal degeneration.
phenotype when challenged in settings designed to test
the limits or more subtle aspects of neuronal function. Experimental Procedures
Breeding and Genotyping of Mice with Different Gene
Dosages of BaxCells Protected by BCL2 Family Members from
Mice heterozygous for Bax (Knudson et al., 1995) were mated toDeath Retain Cell Type–Specific Characteristics
yield F1 offspring with Bax 2/2, Bax 1/2, and wild-type genotypes.Inhibition by BCL2 family members of the progression
At the developmental age detailed below, tail DNA was prepared
of degeneration toward cell death preserves cells at a and screened for both the normal and the mutant allele using a
stage at which they display several seemingly normal single polymerase chain reaction. The normal allele was amplified
responses, such as the expression of cell type–specific using an exon 5 forward primer (0.64 mM: 59-TGATCAGAACCATC
ATG-39) and an intron 5 reverse primer (0.64 mM: 59-GTTGACCAGAGproperties and the ability to mount classical anabolic
TGGCGTAGG-39), which together generated a 304 bp product. Theresponses to trophic factors. Bax 2/2 sympathetic neu-
mutant allele was amplified with a neo/pgk primer (0.16 mM:rons spontaneously extend neurites even in the absence
59-CCGCTTCCATTGCTCAGCGG-39) and the same intron 5 reverse
of NGF, indicating that these salvaged neurons still ex- primer, which together generated a 507bp product. Cycling parame-
press a hallmark of the neuronal phenotype, i.e., the ters were 1 min at 948C, 558C, and 728C each for a total of 30–35
elaboration of neurites. Along similar lines, it has been cycles. The primer ratio was adjusted to allow amplification of both
products simultaneously with preferential amplification of the wild-shown recently that facial motor neurons that survive
type allele to assure correct genotyping of the Bax-deficient animals.axotomy when overexpressing BCL2 retain their electro-
The genotype of some of the litters was also examined by Southernphysiological properties (Alberi et al., 1996). These ob-
hybridization (Knudson et al., 1995).
servations extend beyond the nervous system and are
parallel to findings in the immune system in which over-
Sympathetic Neuronal Cultures
expressed BCL2 not only prevented cell death, but also Primary cultures of sympathetic neurons were established from the
promoted differentiation of immature lymphocytes (Li- two SCGs of every F1 offspring from Bax 1/2 3 Bax 1/2 matings
nette et al., 1994), and reminiscent of observations in 1 day after birth using a modification of a previously published
procedure (Deckwerth and Johnson,1994). The genotypewas deter-nematode development in which cells rescued from de-
mined from tail DNA after the cultures had been established. Invelopmental cell death by loss-of-function mutations in
brief, the two ganglia were dissected, digested with collagenaseCed3 and Ced4 acquire distinct phenotypes (Ellis and
and dispase, dissociated by trituration, and plated at 3–5.5 3 103
Horvitz, 1986). The ability of trophic factor–deprived Bax trypan-blue excluding dissociated cells (neurons, fibroblasts, and
2/2 neurons to extend neurites in the absence of NGF Schwann cells) onto collagen-coated two-well chamber slides in 30
complements the finding by Martinou et al. (1994), who ml of MEM (Earle’s salts) supplemented with 10% fetal calf serum.
Between 4 and 30 cultures of the same plating density were estab-demonstrated that facial motor neurons overexpressing
lished from each offspring, depending on the number of trypan-bluehuman BCL2 retained their axons in addition tosurviving
negative cells available. After allowing the neurons to adhere fordevelopmental neuronal death. The beneficial effects
30–40 min, 1.5 ml of culture medium (MEM, 10% fetal calf serum, 100
of BCL2 family members on neurites are particularly U/ml penicillin, 100 mg/ml streptomycin, and 3.3 mg/ml aphidicolin to
noteworthy, since axons and dendrites are neuronal kill contaminating dividing non-neuronal cells) containing 50 ng/ml
compartments with a great degree of independence 2.5S mouse NGF or 0.025% goat anti-2.5S mouse NGF antiserum
were added per well. The medium was changed every 3–4 days.from the soma. The protection of neurites by BCL2 family
While different cultures from the same offspring had similarnumbersmembers does not extend to any insult, however. In
of neurons when examined by crystal violet staining (see below),mice suffering from progressive motor neuronopathy,
after several days to weeks in the presence of NGF, the number of
motor axons degenerate while motor neuronal somas neurons in cultures from different animals was more variable
remain protected by Bcl2 overexpression (Sagot et al., (1–4.7 3 103/culture). To deprive established NGF-maintained neu-
1995). rons of NGF, the medium was replaced with medium lacking NGF
and containing 0.025% goat anti-2.5S mouse NGF antiserum. ToBax-deficient mice constitute a genetic model with a
expose neurons to NGF after having been cultured with anti-NGFdefect in a distal common pathway of cell death. In
antiserum, the medium was exchanged twice with medium con-addition to remaining alive, the salvaged trophic factor–
taining NGF.
deprived Bax 2/2 neurons express a neuronal pheno-
type, remain responsive to trophic factors, and display
Sympathetic Neuron Analysis
anabolic responses. This argues that in addition to the Living neurons in freshly dissociated ganglia were quantitated after
retention of at least some normal functional responses, plating the neurons for 2 hr, fixing the cultures with 4% paraformal-
dehyde (PFA) in phosphate-buffered saline (PBS) (4% PFA), andthe degenerative changes induced by trophic factor
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staining with 1:100 sheep anti-rat tyrosine hydroxylase (TH) antise- antisense riboprobes containing exons 4–6 were prepared from mu-
rine Bax cDNA (Oltvai et al., 1993) by digestion of the vector withrum (Chemicon, Temecula, CA), 1:400 Cy3-labeled donkey anti-
sheep IgG (Jackson ImmunoResearch, West Grove, PA), and 1 mg/ Pst1 and synthesis of the cRNA using T7 RNA polymerase and
[33P]UTP as label. The specificity of the detection of Bax mRNA wasml Hoechst 33258 (Molecular Probes, Eugene, OR). Cells with TH-
positive cytoplasm and healthy nuclei were counted as living neu- controlled for by hybridization with a Bax mRNA sense probe.
rons. About 12–15 parallel stripes sampling representative 30% of
the whole area of each culture were analyzed. Viability of sympa- Acknowledgments
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